{
    "nctId": "NCT05049031",
    "briefTitle": "Impact of Adjuvant Hormone Therapy on Bone and Cardiovascular Risk",
    "officialTitle": "Study of the Impact of Adjuvant Hormone Therapy on Bone and Cardiovascular Risk After Initial Treatment in Patients With Non-metastatic Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 102,
    "primaryOutcomeMeasure": "Evaluate the bone impact of hormone therapy remotely",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Adult patients who had T1-T3, N0-N2, M0 breast cancer\n* Patients referred to the Menopause center in the context of their breast cancer who were included in the original study evaluating the bone impact of hormone therapy carried out between 2010 \"Bone and cardiovascular impact of adjuvant hormone therapy for cancer non-metastatic breast \"\n* Patient who has given her consent for the study (written or verbal) after clear and fair information\n\nExclusion Criteria:\n\n* Metastatic breast tumor\n* Absence of adjuvant hormone therapy for patients whose tumor did not express hormone receptors\n* Patients who have died since the last assessment\n* Protected adult patient (guardianship, curatorship, safeguard of justice)",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}